Thomas Dolca 4
4 · Allakos Inc. · Filed May 15, 2025
Insider Transaction Report
Form 4
Allakos Inc.ALLK
Thomas Dolca
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-05-15−154,786→ 0 totalExercise: $5.55Exp: 2033-08-01→ Common Stock (154,786 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-05-15−41,000→ 0 totalExercise: $1.42Exp: 2034-05-24→ Common Stock (41,000 underlying)
Footnotes (1)
- [F1]This option was cancelled without consideration pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc.